Company news
Inspiremd Inc. (NASDAQ:NSPR) news
Every Inspiremd Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
InspireMD to Announce Second Quarter 2026 Financial Results
August 10, 2026
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
July 30, 2026
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
June 11, 2026
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR...
June 8, 2026
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
May 6, 2026
InspireMD Reports First Quarter 2026 Financial Results
May 4, 2026
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neur...
May 1, 2026
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
May 1, 2026
InspireMD to Announce First Quarter 2026 Financial Results
April 27, 2026
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
March 9, 2026
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2026
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
January 12, 2026
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
November 24, 2025
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
InspireMD Reports Third Quarter 2025 Financial Results
November 4, 2025
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
November 3, 2025
InspireMD to Announce Third Quarter 2025 Financial Results
October 21, 2025
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
October 9, 2025
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
September 17, 2025
InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference
August 27, 2025
InspireMD Reports Second Quarter 2025 Financial Results
August 5, 2025
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
August 4, 2025
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
July 31, 2025
InspireMD Announces Combined Financings of $58 Million
July 31, 2025
InspireMD to Announce Second Quarter 2025 Financial Results
July 22, 2025
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
July 9, 2025
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
June 24, 2025
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
June 13, 2025
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
June 3, 2025
InspireMD Reports First Quarter 2025 Financial Results
May 9, 2025
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
April 30, 2025
InspireMD to Announce First Quarter 2025 Financial Results
April 25, 2025
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR pr...
February 13, 2025
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
December 12, 2024
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Ar...
December 9, 2024
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
November 25, 2024
InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th
November 4, 2024
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of th...
October 15, 2024
InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80...
October 7, 2024
InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Ste...
September 16, 2024
InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
August 6, 2024
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
July 1, 2024
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) ...
May 28, 2024
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024